发明名称 |
ACTIVATION OF HCV-SPECIFIC T CELLS |
摘要 |
<p>Methods for activating HCV-specific T cells are described. The methods utilize one or more administrations of HCV protein compositions, followed by one or more administrations of a viral vector comprising a nucleic acid encoding a least one HCV epitope that is present in the first composition. The protein compositions can further comprise an immunostimulatory nucleic acid and or other adjuvants and immune stimulatory compounds.</p> |
申请公布号 |
EP1981537(A4) |
申请公布日期 |
2009.06.17 |
申请号 |
EP20070709585 |
申请日期 |
2007.01.04 |
申请人 |
NOVARTIS VACCINES AND DIAGNOSTICS, INC. |
发明人 |
HOUGHTON, MICHAEL;LIN, YIN-LING |
分类号 |
A61K39/29 |
主分类号 |
A61K39/29 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|